25 Sep 2025 | 3 Mins Read
Ajanta Pharma drops 2.02%, leads Nifty Midcap 150 decliners
Flipitmoney
Ajanta Pharma shares declined 2.02% to Rs 2,480.00, being one of the top Nifty Midcap 150 losers. Consolidated 2024-25 revenue reached Rs 4,648.10 crore with a net profit of Rs 920.39 crore, a 12.86% increase from the previous year. Key financial ratios include a basic EPS of Rs 73.56 and a debt to equity ratio of 0.00 as of March 2025.